Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc.
1:09-cv-00184
Overview
Parties
Defendant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
12 Attorneys ListedDoungamon Fon Muttamara-Walker
District of Columbia Office of
Administrative Hearings, 441 Fourth Street, N.W.
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Plaintiff
Galderma Laboratories LP NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Galderma Laboratories Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
New York University NPE (University / Research)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Research Foundation of State University of New York NPE (University / Research)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Galderma Laboratories, L.P. v. Sun Pharmaceutical Industries Limited
Galderma Laboratories L.P. v. Amneal Pharmaceuticals LLC
Galderma Laboratories Inc. v. Amneal Pharmaceuticals LLC
Research Foundation of State University of New York v. Impax Laboratories Inc.
Research Foundation of State University of New York v. Lupin Limited
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7232572
Methods of treating rosacea
|
Filed: 2005-02-18
Issued: 2007-06-19
|
Expired (Term Ended)
Expires: 2025-02-18
|
|
|
US5789395
Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
|
Filed: 1996-08-30
Issued: 1998-08-04
|
Expired (Term Ended)
Expires: 2016-08-30
|
|
|
US5919775
Method for inhibiting expression of inducible nitric oxide synthase with tetracycline
|
Filed: 1998-04-16
Issued: 1999-07-06
|
Expired (Term Ended)
Expires: 2018-04-16
|
|
|
US7211267
Methods of treating acne
|
Filed: 2002-04-05
Issued: 2007-05-01
|
Expired (Term Ended)
Expires: 2022-04-05
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
89
Dispositive
54
Granted
12
Denied
1
Pending / Review
56
Motions by Category
Key Dispositive Motions & Rulings